IFF to Sell Food Ingredients Business to CVC in \$4.3 Billion Deal
Key Strategic Portfolio Move to Enhance Focus, Value Creation, and Financial Flexibility
International Flavors & Fragrances Inc. (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health & biosciences, announced a major strategic transaction on May 29, 2026: the company has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager. The deal values the Food Ingredients unit at approximately \$4.3 billion, representing an enterprise value-to-EBITDA multiple of roughly 10x.
Key Transaction Highlights
- Transaction Value: ~\$4.3 billion enterprise value.
- Retained Interest: IFF will keep an approximately 10% minority equity interest in the divested business (valued at ~\$200 million), allowing for continued collaboration and future value participation.
- Expected Closing: By the end of Q2 2027, pending regulatory and customary closing conditions. IFF will also hold a board seat in the new company.
- Proceeds Usage: Estimated net cash proceeds at close are ~\$3.8 billion, earmarked for debt reduction, targeted share repurchases, and reinvestment in high-return growth opportunities across the core portfolio.
Strategic Rationale and Shareholder Impact
-
Portfolio Transformation:
The sale is a significant step in IFF’s multi-year portfolio optimization initiative. Including this transaction, IFF will have divested 13 non-core businesses, generating nearly \$10 billion in gross proceeds. The goal is to strengthen the balance sheet, focus on higher-growth and higher-margin businesses, and support reinvestment in innovation-led segments. -
Sharpened Business Focus:
Post-transaction, IFF will focus on three key market-leading businesses:- Taste: Technology-enabled flavor solutions for global food and beverage customers.
- Scent: Fine and consumer fragrances for personal and home care, plus fragrance ingredients.
- Health & Biosciences: Probiotics, enzymes, cultures, and bioactive health ingredients.
-
Financial Profile:
– IFF expects improved cash flow, greater financial flexibility, and a stronger position to deliver sustained, profitable long-term growth.
– The transaction is anticipated to be dilutive to adjusted EPS in the first 12 months post-closing, before the benefits of capital deployment and overhead cost actions are realized.
– The company has a plan in place to address all stranded overhead costs resulting from the divestiture. -
Guidance Reiteration:
IFF is maintaining its previously communicated 2026 full-year guidance:- Sales: \$10.5 billion to \$10.8 billion.
- Adjusted Operating EBITDA: \$2.05 billion to \$2.15 billion.
- Comparable Currency Neutral Sales Growth: 1% to 4%.
- Comparable Currency Neutral Adjusted Operating EBITDA Growth: 3% to 8%.
Food Ingredients Business Overview
The Food Ingredients business is a globally recognized leader in texturants, emulsifiers, plant-based solutions, and specialty ingredients, serving multinational food and beverage customers. In 2025, it generated nearly \$3.1 billion in sales and about \$430 million of EBITDA.
Statements from Leadership
“This transaction represents an important strategic milestone in our ongoing portfolio optimization initiative, allowing us to further concentrate resources on our higher-growth, higher-margin segments,” said Erik Fyrwald, CEO of IFF. “By simplifying our portfolio to where we can create the greatest value, IFF will accelerate innovation, drive investment in R&D, and further integrate our biotechnology and naturals capabilities more effectively across our global platform. Importantly, by retaining a minority stake in Food Ingredients, we will continue to participate in the future upside of a strong business under dedicated ownership. This transaction creates substantial value for shareholders while positioning IFF to drive sustained, profitable long-term growth.”
Lorne Somerville, managing partner and co-head of North American private equity at CVC, commented: “We are delighted to welcome IFF’s Food Ingredients business to CVC’s U.S. portfolio. The business has built a strong position in an attractive, resilient sector supported by long-term growth trends, including increasing global food consumption and demand for clean-label products. Its global reach and proprietary technical capabilities provide a clear competitive advantage, and we see significant opportunity for continued growth.”
Transaction Advisors
- Financial Advisors: J.P. Morgan Securities LLC (lead), BofA Securities.
- Legal Advisor: Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates.
Potential Share Price Impact & Price-Sensitive Factors
- Material Divestiture: The \$4.3 billion sale is significant relative to IFF’s portfolio and will affect both the company’s revenue base and future earnings profile.
- Near-Term EPS Dilution: The company expects the deal to be dilutive to adjusted EPS in the first year after closing, which could impact market sentiment in the short term.
- Balance Sheet Strengthening: Proceeds will be used to reduce debt, buy back shares, and reinvest in higher-growth segments, all of which could have long-term positive effects on shareholder value.
- Retained Equity Stake: The retention of a 10% minority interest and a board seat allows IFF to benefit from potential future value creation in the divested business.
- Guidance Maintained: The reaffirmation of 2026 outlook may provide confidence to investors regarding IFF’s ongoing operations and strategic direction.
- Regulatory and Closing Risks: As with any large transaction, closing is subject to regulatory approvals and customary conditions, which introduces some uncertainty.
About the Companies
IFF (International Flavors & Fragrances Inc.) is a global leader in flavors, fragrances, food ingredients, and health & biosciences, delivering sustainable innovations that advance wellness, delight senses, and enhance the human experience.
CVC is a leading global private markets manager with approximately €209 billion in assets under management, operating a network of 29 offices worldwide and investing in over 150 companies with combined sales of €240 billion.
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own research or consult a qualified financial advisor before making investment decisions. All forward-looking statements are subject to risks and uncertainties as outlined by IFF and may materially differ from actual results.
